Avigen

Europe, Middle East, and Africa (EMEA)
Avigen is a research orriented firm discovering drugs to accelerate immune cell development.
Founded by
Investors:
British Business Bank, SFC Capital
$
Seed
387582
Biotechnology
Test and Measurement
Wellness
Biotechnology
Data and Analytics
Health Care
Science and Engineering
Description:
Key Metrics:
Total Raised
387582
Team Size
1-10
Location
London
United Kingdom
Last Funding
March 31, 2025
Contacts:
Email
Linkedin
Facebook